Wangsu Science Financials
| 300017 Stock | 9.50 0.28 3.04% |
Operating Margin 0.109 | PE Ratio 37 | Profit Margin 0.1285 | Payout Ratio 0.9812 | EPS Estimate Current Year 0.2 |
Wangsu | Select Account or Indicator |
Understanding current and past Wangsu Science Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Wangsu Science's financial statements are interrelated, with each one affecting the others. For example, an increase in Wangsu Science's assets may result in an increase in income on the income statement.
Please note, the presentation of Wangsu Science's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Wangsu Science's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Wangsu Science's management manipulating its earnings.
Wangsu Science Stock Summary
Wangsu Science competes with Zhuhai Comleader, Tongding Interconnection, Lander Sports, Dalian Zeus, and ButOne Information. Wangsu Science is entity of China. It is traded as Stock on SHE exchange.Specialization | Information Technology, Software - Infrastructure |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100000GQ8 |
| Business Address | Building A, Shanghai, |
| Sector | IT Services |
| Industry | Information Technology |
| Benchmark | Dow Jones Industrial |
| Website | www.wangsu.com |
| Phone | 86 21 2426 1717 |
You should never invest in Wangsu Science without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Wangsu Stock, because this is throwing your money away. Analyzing the key information contained in Wangsu Science's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Wangsu Science Key Financial Ratios
Wangsu Science's financial ratios allow both analysts and investors to convert raw data from Wangsu Science's financial statements into concise, actionable information that can be used to evaluate the performance of Wangsu Science over time and compare it to other companies across industries.| Revenue | 4.71 B | ||||
| Gross Profit | 1.16 B | ||||
| EBITDA | 630.9 M | ||||
| Net Income | 613.1 M | ||||
| Total Asset | 10.97 B |
Wangsu Science Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 10.3B | 10.2B | 10.6B | 10.5B | 11.0B | 5.7B | |
| Other Current Liab | 164.8M | 349.2M | 196.1M | 6.0M | 16.5M | 15.7M | |
| Retained Earnings | 4.1B | 4.2B | 4.4B | 3.9B | 4.3B | 4.5B | |
| Accounts Payable | 879.5M | 708.0M | 705.5M | 748.3M | 568.0M | 386.5M | |
| Cash | 1.6B | 1.2B | 1.0B | 2.5B | 1.8B | 1.3B | |
| Other Assets | 272.5M | 354.9M | 383.5M | 401.8M | 462.1M | 251.9M | |
| Net Receivables | 1.7B | 1.7B | 1.4B | 1.2B | 1.1B | 811.7M | |
| Inventory | 10.3M | 6.1M | 12.2M | 30.5M | 13.5M | 12.8M | |
| Other Current Assets | 213.4M | 136.3M | 340.5M | 462.9M | 285.0M | 250.3M | |
| Total Liab | 1.7B | 1.5B | 1.7B | 1.4B | 1.2B | 990.7M | |
| Common Stock | 2.4B | 2.4B | 2.5B | 2.4B | 2.8B | 3.0B | |
| Intangible Assets | 468.8M | 323.0M | 164.2M | 80.5M | 45.0M | 42.7M | |
| Other Liab | 413.9M | 309.7M | 66.1M | 45.5M | 52.3M | 49.7M | |
| Net Tangible Assets | 7.3B | 8.2B | 8.4B | 8.7B | 10.0B | 7.6B | |
| Total Current Assets | 6.0B | 5.7B | 7.4B | 6.5B | 5.7B | 6.3B | |
| Net Invested Capital | 8.8B | 8.8B | 9.3B | 9.2B | 9.7B | 10.1B | |
| Short Long Term Debt | 135.7M | 145.3M | 503.9M | 144.8M | 80.1M | 76.1M | |
| Net Working Capital | 4.6B | 4.3B | 5.8B | 5.1B | 4.6B | 4.8B | |
| Capital Stock | 2.4B | 2.5B | 2.4B | 2.4B | 2.4B | 2.7B |
Wangsu Science Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 35.8M | 891.9K | 14.1M | 16.4M | 7.6M | 7.1M | |
| Total Revenue | 6.0B | 5.7B | 4.6B | 5.1B | 4.7B | 3.1B | |
| Operating Income | 187.6M | 267.5M | (35.2M) | 211.8M | 398.1M | 330.3M | |
| Cost Of Revenue | 4.5B | 4.2B | 3.4B | 3.8B | 3.2B | 2.1B | |
| Income Before Tax | 21.7M | 218.3M | 137.7M | 194.1M | 651.4M | 382.9M | |
| Net Income | 34.5M | 220.0M | 165.2M | 190.6M | 613.1M | 365.1M | |
| Income Tax Expense | 50.7M | (15.6M) | (1.2M) | (25.9M) | (29.8M) | (28.3M) | |
| Minority Interest | 528.0K | (91.3K) | 1.6M | 6.5M | 6.7M | 7.7M | |
| Research Development | 661.5M | 587.0M | 543.2M | 504.4M | 481.8M | 506.4M | |
| Gross Profit | 1.5B | 1.4B | 1.2B | 1.3B | 1.5B | 1.3B | |
| Ebit | 661.7M | 78.5M | 164.8M | (98.3M) | (88.5M) | (84.0M) | |
| Tax Provision | (15.6M) | (1.2M) | (25.9M) | 9.9M | 45.0M | 47.2M | |
| Net Interest Income | 31.7M | 76.1M | 52.7M | 40.0M | 129.6M | 71.6M | |
| Interest Income | 69.3M | 79.1M | 69.1M | 60.0M | 138.7M | 92.2M | |
| Ebitda | 628.9M | 759.5M | 663.5M | 633.6M | 570.2M | 713.1M |
Wangsu Science Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Wangsu Science Tech. It measures of how well Wangsu is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Wangsu Science brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Wangsu had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Wangsu Science has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 12.0M | 3.9M | (6.7M) | (19.4M) | 11.7M | 12.3M | |
| Dividends Paid | 109.7M | 78.3M | 36.5M | 84.9M | 123.0M | 67.9M | |
| Capital Expenditures | 803.5M | 414.8M | 255.0M | 188.7M | 86.7M | 82.3M | |
| Net Income | 34.5M | 220.0M | 165.2M | 190.6M | 613.1M | 365.1M | |
| Investments | (830.1M) | (597.9M) | (743.9M) | 224.2M | (1.0B) | (1.1B) | |
| Change In Cash | 279.0M | (170.5M) | 118.2M | 604.0M | (213.2M) | (202.6M) | |
| Net Borrowings | 699.2M | (431.8M) | 9.3M | 327.8M | 295.0M | 169.8M | |
| Depreciation | 571.5M | 540.3M | 426.7M | 423.1M | 344.9M | 427.4M | |
| Change To Netincome | (51.1M) | 133.0M | 48.7M | (167.2M) | (192.3M) | (182.7M) | |
| End Period Cash Flow | 1.1B | 895.6M | 1.0B | 1.6B | 1.4B | 1.2B | |
| Free Cash Flow | (192.9M) | 382.7M | 580.7M | 743.0M | 705.0M | 740.3M | |
| Other Non Cash Items | (21.1M) | 41.1M | (34.3M) | (56.3M) | (116.4M) | (110.6M) |
Wangsu Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wangsu Science's current stock value. Our valuation model uses many indicators to compare Wangsu Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wangsu Science competition to find correlations between indicators driving Wangsu Science's intrinsic value. More Info.Wangsu Science Tech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Wangsu Science Tech is roughly 2.93 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Wangsu Science by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Wangsu Science's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Wangsu Science Tech Systematic Risk
Wangsu Science's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Wangsu Science volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Wangsu Science Tech correlated with the market. If Beta is less than 0 Wangsu Science generally moves in the opposite direction as compared to the market. If Wangsu Science Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Wangsu Science Tech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Wangsu Science is generally in the same direction as the market. If Beta > 1 Wangsu Science moves generally in the same direction as, but more than the movement of the benchmark.
Wangsu Science Tech Total Assets Over Time
Wangsu Science November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Wangsu Science help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Wangsu Science Tech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Wangsu Science Tech based on widely used predictive technical indicators. In general, we focus on analyzing Wangsu Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Wangsu Science's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.15 | |||
| Information Ratio | 0.0744 | |||
| Maximum Drawdown | 32.74 | |||
| Value At Risk | (5.23) | |||
| Potential Upside | 6.19 |
Complementary Tools for Wangsu Stock analysis
When running Wangsu Science's price analysis, check to measure Wangsu Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wangsu Science is operating at the current time. Most of Wangsu Science's value examination focuses on studying past and present price action to predict the probability of Wangsu Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wangsu Science's price. Additionally, you may evaluate how the addition of Wangsu Science to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |